If sex has become uncomfortable or you feel dry, itchy, or raw day to day, you are not imagining it and you are far from alone. After menopause, falling estrogen thins and dries the vaginal and vulvar tissues — a cluster of changes clinicians now call genitourinary syndrome of menopause (GSM). Over-the-counter products help most people, but only if you match the product to the problem: moisturizers treat ongoing dryness, while lubricants reduce friction during sex. This guide explains the difference, what to look for on a label, what to avoid, and when it is worth asking your doctor about prescription options.
Moisturizer vs. lubricant: they do different jobs
This is the single most useful distinction to get right, because people often buy a lubricant and wonder why their daytime dryness never improves.
| Feature | Vaginal moisturizer | Lubricant |
|---|---|---|
| Main purpose | Relieve ongoing dryness, restore tissue comfort | Reduce friction during sex |
| How often used | Regularly — often every 2-3 days | As needed, at the time of intercourse |
| How it works | Adheres to tissue and holds water over time | Provides temporary slipperiness on the surface |
| Typical base | Hyaluronic acid or polycarbophil | Water, silicone, or oil |
| Lasts | Up to 2-3 days per application | Minutes to an hour or so |
A moisturizer is used on a schedule, whether or not you are having sex, the way you would moisturize dry skin. It clings to the vaginal lining and holds moisture, so tissue feels less tight and tender over time. A lubricant is used in the moment to make sex more comfortable. Many people with GSM benefit from using both. Guidance from Mayo Clinic and the Menopause Society (NAMS) positions regular moisturizers and as-needed lubricants as reasonable first-line steps for mild to moderate dryness before considering hormonal treatment.
Choosing a vaginal moisturizer
Look for a product labeled specifically as a vaginal moisturizer (not just a lubricant, and not a body lotion). The most common evidence-informed types are:
- Hyaluronic-acid moisturizers — hyaluronic acid is a water-binding molecule; some studies suggest hyaluronic-acid vaginal gels can relieve dryness for people who prefer to avoid, or cannot use, hormones.
- Polycarbophil-based moisturizers — these bioadhesive gels stick to the vaginal wall and release moisture over a few days; they are among the longest-studied over-the-counter options.
Use a moisturizer consistently for at least a few weeks before judging it. Because it works cumulatively, a single application will not tell you much. Apply at bedtime if daytime leakage feels awkward.
What to look for on the label
- pH-balanced. A healthy premenopausal vagina is acidic. Sexual-health product guidance favors lubricants near natural vaginal pH (roughly 3.8-4.5); many mass-market products fall well outside this range. Formulas closer to vaginal pH are gentler on tissue and the microbiome.
- Low osmolality. Osmolality measures how much a product pulls water out of, or pushes it into, cells. Very high-osmolality products can draw water out of and irritate the delicate vaginal lining; lower, more physiologically balanced osmolality is preferable. Brands rarely print this number — a reason to favor products marketed for sensitive or menopausal tissue.
- Short, simple ingredient list. Fewer additives means fewer things to react to.
Choosing a lubricant for sex
Lubricants come in three main bases, each with trade-offs.
| Base | Pros | Cons | Condom-safe? |
|---|---|---|---|
| Water-based | Easy to clean, widely available, latex-safe | Dries out faster; may need reapplying | Yes |
| Silicone-based | Long-lasting, very slippery, good for dryness | Harder to wash off; can degrade silicone toys | Yes |
| Oil-based | Long-lasting, moisturizing feel | Degrades latex condoms; can trap bacteria | No — not with latex |
An important safety point: oil-based lubricants (including petroleum jelly, baby oil, and many natural oils) can weaken latex condoms and diaphragms, causing them to break. If you rely on latex barriers for contraception or STI protection, choose a water- or silicone-based product. This is worth remembering — pregnancy and infection are still possible during perimenopause.
Ingredient considerations
- Glycerin. Common in water-based lubes; it can raise osmolality and, for some people, is associated with irritation or yeast overgrowth. If you are prone to yeast infections, a glycerin-free option may suit you better.
- Parabens. These preservatives are a source of debate. Evidence of real-world harm at the levels used is limited, but if you prefer to avoid them, paraben-free products are easy to find.
- Warming, tingling, or flavored additives. These frequently irritate already-sensitive tissue. For GSM, plainer is usually kinder.
- Fragrance and "freshening" agents. Skip them. The vulva does not need perfume, and fragrance is a common irritant.
What to avoid
Some popular home remedies do more harm than good:
- Douching — it disrupts the natural microbiome and can worsen dryness and infection risk. Cleveland Clinic and other sources advise against it.
- Petroleum jelly and body lotions inside the vagina — not formulated for this tissue, and petroleum products damage latex.
- Scented "feminine hygiene" sprays and wipes — common irritants with no benefit.
- Very high-osmolality or extreme-pH products — these can paradoxically dry and inflame tissue.
What the pooled evidence actually found
Almost every moisturizer on the shelf can point to one small trial showing it helped. That is a low bar: a single 30-woman study with no blinding and a four-week follow-up will usually show improvement, because vaginal dryness scores improve on placebo too. Systematic reviews are the corrective — teams pre-register a search, screen every trial that meets the criteria including the unflattering ones, grade how trustworthy each is, and only then say what the evidence supports. When a review says the certainty is "low," that is information you are paying for.
Three reviews carry most of the weight here, and it is worth knowing up front that none of them delivers the clean head-to-head number a shopper would want.
The most authoritative is the systematic review by Danan and colleagues in Annals of Internal Medicine (2024)[s1]. Screening 11,993 citations, they included 46 randomized trials of at least eight weeks in postmenopausal women with at least one GSM symptom — 22 of vaginal estrogen, 16 of non-estrogen hormones, 4 of vaginal moisturizers, and 4 comparing multiple interventions. Their finding on moisturizers is exactly one clause long: they may improve dryness, at low certainty of evidence. Vaginal estrogen, against placebo or no treatment, may improve dryness, painful sex, most bothersome symptom, and treatment satisfaction — also at low certainty. The decisive detail is what they could not do: they judged the trials too varied in population, intervention, comparator and outcome to pool at all, so this review produces no meta-analysed effect size for moisturizer versus estrogen.
The strongest numbers for a specific non-hormonal ingredient come from Dahab, Ramasamy and Ibrahim in the International Journal of Gynaecology and Obstetrics (2026)[s2], a meta-analysis of 11 randomized trials of hyaluronic acid, with three placebo-controlled RCTs supplying the primary pooled evidence. Against placebo, hyaluronic acid improved the Vaginal Health Index (SMD 3.40, 95% CI 2.73 to 4.06), dryness-related quality of life (SMD -0.98, 95% CI -1.24 to -0.71) and Female Sexual Function Index scores (SMD 0.85, 95% CI 0.50 to 1.20). No serious adverse events were reported. GRADE certainty was moderate for dryness and sexual function, but only low for vaginal health and safety outcomes because of heterogeneity and publication bias concerns. In comparative studies, the authors report hyaluronic acid was not inferior to active comparators.
The one review built specifically around the comparison a buyer cares about is Albalawi and colleagues in Cureus (2023)[s3]: 6 studies, 411 women randomized to vaginal hyaluronic acid or vaginal estrogen. Both arms improved significantly from their own baseline. Counting outcomes between groups, estrogen came out ahead on symptom relief in most comparisons, on vaginal pH in 2 of 3 studies reporting it (the third showed no significant difference), and on vaginal cell maturation in all 3 studies reporting it, 2 of them significantly. The authors' own verdict is more balanced than that tally implies: they judged topical hyaluronic acid effective and safe, called its efficacy comparable to estrogen, and supported it as a first-line option in mild atrophy, with estrogen for moderate-to-severe symptoms or for women who do not respond. They also state plainly that the trials were largely unblinded, that randomization was asserted without documentation in all but two, that groups differed at baseline without adjustment, and that treatment ran "far below the recommended 12 weeks duration" in most studies — and were too heterogeneous to meta-analyse. This is also the weakest of the three sources on publication venue: Cureus has a substantially lower barrier to publication than the other two journals.
| Question a buyer is asking | What the reviews actually say | How confident the reviewers were |
|---|---|---|
| Do OTC moisturizers do anything at all for dryness? | Yes — moisturizers "may improve dryness" across 4 moisturizer trials in the 46-trial review[s1]; hyaluronic acid beat placebo on dryness QoL (SMD -0.98) and sexual function (SMD 0.85)[s2]. | Low certainty in the Annals review; moderate (dryness, sexual function) in the HA meta-analysis. |
| Is a moisturizer as good as vaginal estrogen? | No pooled answer exists. The largest review could not meta-analyse the comparison at all[s1]. In the 411-woman head-to-head review, estrogen was ahead on most individual symptom comparisons, though those same authors concluded hyaluronic acid is a comparable and reasonable alternative, first-line in mild atrophy[s3]; the HA meta-analysis reported HA was not inferior to active comparators[s2]. The per-outcome direction and the reviewers' overall verdicts do not line up neatly. | Weak. Small unblinded trials, short follow-up, no pooling. |
| Do they change the tissue itself, not just how it feels? | This is where the two diverge most clearly. Estrogen outperformed hyaluronic acid on vaginal pH (2 of 3 studies) and on vaginal cell maturation (all 3 studies reporting it, 2 significantly)[s3]. | Few studies, but consistent in direction. |
| Are moisturizers safe? | No serious adverse events reported in the HA meta-analysis (RR 0.35, 95% CI 0.10 to 1.23), with minimal discontinuations[s2]. | Low certainty for safety specifically — the trials were small and short. |
| Will it still work in a year? | Unknown. Most trials ran 12 weeks or less[s1], and most head-to-head studies ran shorter than that[s3]. Reviewers in all three call for long-term evaluation. | No evidence either way. |
The honest bottom line. Buying a moisturizer is a reasonable, low-risk thing to do, and the pooled data support real improvement in dryness and sexual comfort — particularly for hyaluronic-acid-based products, the non-hormonal category with the strongest meta-analysed evidence behind it. What you are not buying is demonstrated equivalence to vaginal estrogen. The evidence base is thin in three specific places, and no marketing claim can paper over them: no review has been able to pool a moisturizer-versus-estrogen comparison, the one review designed around that comparison found estrogen ahead on most symptom measures and on the physical markers of tissue change even as its authors judged hyaluronic acid a reasonable alternative, and essentially nothing is known beyond about 12 weeks. Reviewers also flagged publication bias and non-standardised formulations, which means results from one branded product do not automatically transfer to another with a different formula. Treat the price of a moisturizer as the cost of a short trial of something that often helps — and treat any product page implying it is proven to match prescription therapy as making a claim the published evidence does not currently support. What is right for your body is a conversation for your clinician, not a shelf label.
When to talk to your doctor about prescription options
Moisturizers and lubricants are excellent for mild to moderate symptoms, but they do not restore the tissue itself. If dryness, pain with sex, urinary urgency, or recurrent irritation persists despite consistent over-the-counter use, it is worth a conversation about prescription treatments — which act on the underlying tissue changes. The American College of Obstetricians and Gynecologists notes that these symptoms are treatable and worth raising with a clinician rather than enduring.
The most established option is low-dose vaginal estrogen, available as a cream, tablet, insert, or ring. Because it is delivered locally, very little is absorbed into the bloodstream, and major menopause organizations consider it effective and generally well tolerated for GSM. Other prescription options include vaginal DHEA (prasterone) and the oral medication ospemifene. Each has its own considerations, and suitability depends on your personal and medical history — including any history of hormone-sensitive cancer, which is an important thing to raise.
These are prescription decisions to make with a clinician who knows your history. We are deliberately not listing doses here — the right product, strength, and schedule are individual, and self-directing hormone therapy is not safe or effective in the way a tailored plan is.
You should also see a clinician promptly — rather than reaching for a moisturizer — if you have any bleeding after menopause, new lumps, sores, or one-sided or worsening pain. These need evaluation, not a lubricant.
A simple starting plan
- Buy a pH-balanced vaginal moisturizer (hyaluronic-acid or polycarbophil) and use it regularly, not just before sex.
- Keep a water- or silicone-based lubricant for intercourse — silicone if you want longer-lasting slip.
- Avoid oil-based products with latex condoms; skip fragrance, warming agents, and douching.
- Give it 2-4 weeks. If symptoms persist, book a visit to discuss vaginal estrogen or other prescription options.
Dryness after menopause is common, treatable, and nothing to be embarrassed about. The right product often makes a real difference — and when it does not, effective medical treatment exists.
Related: Dryness and odor questions often overlap — see Vaginal Odor: Causes and What Helps.
